Skip to main content
Clinical Trials/ACTRN12622000996763
ACTRN12622000996763
Completed
未知

Pharmacist-led Intervention for Disease and Risk Management in Patients with Ischemic Heart Disease

Dr. Amjad Khan0 sites330 target enrollmentJuly 15, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Ischemic Heart Disease
Sponsor
Dr. Amjad Khan
Enrollment
330
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 15, 2022
End Date
December 31, 2022
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dr. Amjad Khan

Eligibility Criteria

Inclusion Criteria

  • Patients with confirmed ischemic heart diseases (e.g Myocardial infarction, angina, history of atherosclerosis) who are admitted to and taking follow\-up treatment in the Punjab Institute of Cardiology (PIC) hospital will be recruited for the study. Patients with a previous history of coronary heart disease will also be included. Informed consent will be taken from the patients before conducting the study

Exclusion Criteria

  • Cardiovascular patients other than ischemic heart diseases will be excluded from the study. Patients who have a shorter stay in the hospital, do not have to ability to self\-care, cognitively impaired patients, allergic or contraindicated to cardiovascular medicines, have communicable diseases, and could not complete the study due to hepatic or renal insufficiencies and refused to include in the study would be excluded from the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials